Neil M. Kernohan

948 total citations
28 papers, 731 citations indexed

About

Neil M. Kernohan is a scholar working on Oncology, Molecular Biology and Surgery. According to data from OpenAlex, Neil M. Kernohan has authored 28 papers receiving a total of 731 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Oncology, 11 papers in Molecular Biology and 6 papers in Surgery. Recurrent topics in Neil M. Kernohan's work include Cancer-related Molecular Pathways (7 papers), Cutaneous Melanoma Detection and Management (3 papers) and Lymphoma Diagnosis and Treatment (3 papers). Neil M. Kernohan is often cited by papers focused on Cancer-related Molecular Pathways (7 papers), Cutaneous Melanoma Detection and Management (3 papers) and Lymphoma Diagnosis and Treatment (3 papers). Neil M. Kernohan collaborates with scholars based in United Kingdom, United States and Saudi Arabia. Neil M. Kernohan's co-authors include Susan E. Bray, R. Steele, Francis A. Carey, David A. Levison, Lynne S. Cox, Mirsada Čaušević, Frances V. Fuller-Pace, Richard Kay, Robert Hislop and Karen Murray and has published in prestigious journals such as The Lancet, Journal of Biological Chemistry and Oncogene.

In The Last Decade

Neil M. Kernohan

28 papers receiving 710 citations

Peers

Countries citing papers authored by Neil M. Kernohan

Since Specialization

Citations

This map shows the geographic impact of Neil M. Kernohan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Neil M. Kernohan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Neil M. Kernohan more than expected).

Fields of papers citing papers by Neil M. Kernohan

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Neil M. Kernohan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Neil M. Kernohan. The network helps show where Neil M. Kernohan may publish in the future.

Co-authorship network of co-authors of Neil M. Kernohan

This figure shows the co-authorship network connecting the top 25 collaborators of Neil M. Kernohan. A scholar is included among the top collaborators of Neil M. Kernohan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Neil M. Kernohan. Neil M. Kernohan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	The amino-acid stress sensing eIF2α kinase GCN2 is a survival biomarker for malignant mesothelioma 2023 ·PubMed ·(unknown), Susan E. Bray, Neil M. Kernohan, (unknown), (unknown), Glenn R. Masson	1
2	Multimodality Characterization of Cancer-Associated Fibroblasts in Tumor Microenvironment and Its Correlation With Ultrasound Shear Wave-Measured Tissue Stiffness in Localized Prostate Cancer 2022 ·Frontiers in Oncology ·(unknown), Xinyu Zhang, (unknown), Susan E. Bray, Neil M. Kernohan, Jennifer A. Wilson, Chunhui Li, Ghulam Nabi	5
3	Phenformin as prophylaxis and therapy in breast cancer xenografts 2012 ·British Journal of Cancer ·M. Virginia C. L. Appleyard, Karen Murray, Philip J. Coates, Stephan Wullschleger, Susan E. Bray, Neil M. Kernohan, S. Fleming, Dario R. Alessi, Anne M. Thompson	89
4	Gene expression in colorectal neoplasia: modifications induced by tissue ischaemic time and tissue handling protocol 2009 ·Histopathology ·Susan E. Bray, F. Paulin, (unknown), (unknown), (unknown), David A. Levison, R. Steele, Neil M. Kernohan	41
5	Seliciclib (CYC202, R‐roscovitine) enhances the antitumor effect of doxorubicin in vivo in a breast cancer xenograft model 2008 ·International Journal of Cancer ·(unknown), Mary O’Neill, Karen Murray, F. Paulin, Susan E. Bray, Neil M. Kernohan, David A. Levison, David P. Lane, Alastair M. Thompson	43
6	BCL2 gene abnormalities define distinct clinical subsets of follicular lymphoma 2006 ·Histopathology ·John R. Goodlad, Paul Batstone, (unknown), Neil M. Kernohan, David A. Levison, Joanne White	30
7	Lesions resembling Langerhans cell histiocytosis in association with other lymphoproliferative disorders: a reactive or neoplastic phenomenon? 2005 ·Human Pathology ·Lesley Christie, Alan Evans, Susan E. Bray, Mark E. Smith, Neil M. Kernohan, David A. Levison, John R. Goodlad	50
8	Differential effects of 5-aminolaevulinic acid photodynamic therapy and psoralen + ultraviolet A therapy on p53 phosphorylation in normal human skin in vivo 2005 ·British Journal of Dermatology ·Lee Finlan, Neil M. Kernohan, George Thomson, Paula Beattie, (unknown), Sally H. Ibbotson	19
9	Activity of MDI-301, a novel synthetic retinoid, in xenografts 2004 ·Anti-Cancer Drugs ·Virginia Appleyard, (unknown), Karen Murray, Susan E. Bray, George Thomson, Neil M. Kernohan, James Varani, Jian Zhang, Alastair M. Thompson	7
10	Alteration of glutathione S-transferase levels in Barrett's metaplasia compared to normal oesophageal epithelium 2003 ·European Journal of Gastroenterology & Hepatology ·(unknown), (unknown), Elizabeth Pöhler, John D. Hayes, Neil M. Kernohan, John Dillon	14
11	Overexpression and poly-ubiquitylation of the DEAD-box RNA helicase p68 in colorectal tumours 2001 ·Oncogene ·Mirsada Čaušević, Robert Hislop, Neil M. Kernohan, Francis A. Carey, Richard Kay, R. Steele, Frances V. Fuller-Pace	120
12	Chromosomal imbalances in gastric and esophageal adenocarcinoma: Specific comparative genomic hybridization–detected abnormalities segregate with junctional adenocarcinomas 2001 ·Genes Chromosomes and Cancer ·S. Craig Stocks, Norman Pratt, Mark Sales, David A. Johnston, Alastair M. Thompson, Francis A. Carey, Neil M. Kernohan	20
13	Modification of an N-terminal Regulatory Domain of T Antigen Restores p53-T Antigen Complex Formation in the Absence of an Essential Metal Ion Cofactor 1996 ·Journal of Biological Chemistry ·Neil M. Kernohan, Ted R. Hupp, David P. Lane	14
14	EDITORIAL. REGULATION OF APOPTOSIS BY Bcl-2 AND ITS RELATED PROTEINS: IMMUNOCHEMICAL CHALLENGES AND THERAPEUTIC IMPLICATIONS 1996 ·The Journal of Pathology ·Neil M. Kernohan, Lynne S. Cox	40
15	Skin Lesion Removal: Practice by General Practitioners in Grampian Region before and after April 1990 1992 ·Scottish Medical Journal ·Patrick A. Brown, Neil M. Kernohan, (unknown), (unknown), P L Atkinson, (unknown), David W. Russell, (unknown)	6
16	Natural killer cells in cutaneous malignant melanoma 1990 ·The Journal of Pathology ·Neil M. Kernohan, H. F. Sewell, Francesca Walker	10
17	Cystadenocarcinoma of the appendix testis 1990 ·Histopathology ·Neil M. Kernohan, (unknown), P. V. Best	15
18	Interleukin‐2 receptor expression in benign and malignant melanocytic skin lesions 1989 ·The Journal of Pathology ·Neil M. Kernohan, H. F. Sewell	3
19	Fatal Haemophitus influenzae endocarditis 1989 ·Journal of Infection ·Neil M. Kernohan, Alistair Paterson	6
20	S‐100 protein: a prognostic indicator in cutaneous malignant melanoma? 1987 ·Histopathology ·Neil M. Kernohan, R Rankin	17

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact